These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 3746074

  • 1. [Concomitant therapy with prednisolone and cyclophosphamide in 18 cases of IgA nephropathy].
    Kawaguchi S, Matsuzaki T, Sato R, Katsumata Y.
    Nihon Naika Gakkai Zasshi; 1986 May; 75(5):611-7. PubMed ID: 3746074
    [No Abstract] [Full Text] [Related]

  • 2. Concomitant therapy with prednisolone and cyclophosphamide in 17 cases with IgA nephropathy.
    Katsumata Y, Hasegawa K, Hoshino K.
    Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):295-302. PubMed ID: 4021193
    [No Abstract] [Full Text] [Related]

  • 3. Combination of pulse cyclophosphamide and steroids in crescentic IgA nephropathy.
    Ramachandran R, Doddi P, Nandakrishna B, Nada R, Kumar V, Rathi M, Kohli HS, Jha V, Sakhuja V, Gupta KL.
    Int Urol Nephrol; 2015 Nov; 47(11):1917-8. PubMed ID: 26411427
    [No Abstract] [Full Text] [Related]

  • 4. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW, Fluck RJ, Lambie SH.
    Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
    [Abstract] [Full Text] [Related]

  • 5. Effect of corticosteroid and cyclophosphamide in IgA nephropathy patients with heavy proteinuria and/or moderate-severe pathological changes.
    Chen KJ, Cheng CH, Wu MJ, Chen CH, Shu KH.
    J Chin Med Assoc; 2003 May; 66(5):263-70. PubMed ID: 12908567
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of patients with IgA nephropathy treated with prednisolone and cyclophosphamide therapy.
    Oshima S, Kawamura O.
    Clin Exp Nephrol; 2008 Aug; 12(4):264-269. PubMed ID: 18324350
    [Abstract] [Full Text] [Related]

  • 7. Treatment of vasculitic IgA nephropathy.
    Harper L, Ferreira MA, Howie AJ, Savage CO, Richards NT, Michael J, Adu D.
    J Nephrol; 2000 Aug; 13(5):360-6. PubMed ID: 11063140
    [Abstract] [Full Text] [Related]

  • 8. An adolescent with IgA nephropathy and Crohn disease: pathogenetic implications.
    Takemura T, Okada M, Yagi K, Kuwajima H, Yanagida H.
    Pediatr Nephrol; 2002 Oct; 17(10):863-6. PubMed ID: 12376818
    [Abstract] [Full Text] [Related]

  • 9. Treating IgA Nephropathy - Who, When and How?
    Feehally J.
    Nephron Clin Pract; 2003 Oct; 93(2):C47-8. PubMed ID: 12616029
    [No Abstract] [Full Text] [Related]

  • 10. Clinical course of patients with IgA nephropathy between combined treatment of immunosuppressive agents and ACE inhibitor and ACE inhibitor alone.
    Hwang YC, Lee TW, Kim MJ, Yang MH, Ihm CG.
    Korean J Intern Med; 2001 Jun; 16(2):105-9. PubMed ID: 11590896
    [Abstract] [Full Text] [Related]

  • 11. Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
    Shima Y, Nakanishi K, Kamei K, Togawa H, Nozu K, Tanaka R, Sasaki S, Iijima K, Yoshikawa N.
    Nephrol Dial Transplant; 2011 Jan; 26(1):163-9. PubMed ID: 20601366
    [Abstract] [Full Text] [Related]

  • 12. Evidence for abundant presence of chymase-positive mast cells in the kidneys of patients with immunoglobulin A nephropathy: effect of combination therapy with prednisolone and angiotensin II receptor blocker valsartan.
    Konishi Y, Morikawa T, Okada N, Maeda I, Kitabayashi C, Yoshioka K, Okumura M, Nishiyama A, Ueda M, Takai S, Miyazaki M, Imanishi M.
    Hypertens Res; 2008 Aug; 31(8):1517-24. PubMed ID: 18971525
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of methylprednisolone, cyclophosphamide in pediatric IgA nephropathy assessed by renal biopsy.
    Jiang XY, Mo Y, Sun LZ, Yue ZH, Chen SM, Wu W.
    Clin Nephrol; 2009 Jun; 71(6):625-31. PubMed ID: 19473630
    [Abstract] [Full Text] [Related]

  • 14. Combined therapy in children and adolescents with IgA nephropathy.
    Murakami K, Yoshioka K, Akano N, Takemura T, Okada M, Aya N, Hino S, Miyazato H, Yagi K, Maki S.
    Nihon Jinzo Gakkai Shi; 1994 Jan; 36(1):38-43. PubMed ID: 8107307
    [Abstract] [Full Text] [Related]

  • 15. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
    Tsuruya K, Harada A, Hirakata H, Mitsuiki K, Johko T, Kondoh H, Takechi S, Fujishima M.
    Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476
    [Abstract] [Full Text] [Related]

  • 16. Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy.
    Rasche FM, Klotz CH, Czock D, Karges W, Muche R, Jehle PM, Mertz A, Keller F.
    Nephron Clin Pract; 2003 Jan; 93(4):c131-6. PubMed ID: 12759581
    [Abstract] [Full Text] [Related]

  • 17. Unusual presentation of IgA nephropathy in childhood: a case report.
    Cengiz N, Baskin E, Agras PI, Bilezikci B, Saatci U.
    Ren Fail; 2005 Jan; 27(6):795-9. PubMed ID: 16350837
    [Abstract] [Full Text] [Related]

  • 18. Glomerular morphology, natural history and treatment of children with IgA-IgG mesangial nephropathy.
    McEnery PT, McAdams AJ, West CD.
    Perspect Nephrol Hypertens; 1973 Jan; 1 Pt 1():305-20. PubMed ID: 4620921
    [No Abstract] [Full Text] [Related]

  • 19. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M, Jafri J, Bartosh SM, Karp SL, Adler SG, Meehan SM.
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [Abstract] [Full Text] [Related]

  • 20. IgA nephropathy in children.
    Yoshikawa N, Iijima K, Ito H.
    Nephron; 1999 Sep; 83(1):1-12. PubMed ID: 10461030
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.